Cargando…
Maintenance ramucirumab monotherapy after intolerable toxicities following docetaxel plus ramucirumab
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033353/ https://www.ncbi.nlm.nih.gov/pubmed/29983860 http://dx.doi.org/10.18632/oncotarget.25623 |
| _version_ | 1783337684490518528 |
|---|---|
| author | Hata, Akito Katakami, Nobuyuki |
| author_facet | Hata, Akito Katakami, Nobuyuki |
| author_sort | Hata, Akito |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6033353 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60333532018-07-08 Maintenance ramucirumab monotherapy after intolerable toxicities following docetaxel plus ramucirumab Hata, Akito Katakami, Nobuyuki Oncotarget Letter to the Editor Impact Journals LLC 2018-06-19 /pmc/articles/PMC6033353/ /pubmed/29983860 http://dx.doi.org/10.18632/oncotarget.25623 Text en Copyright: © 2018 Hata et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Letter to the Editor Hata, Akito Katakami, Nobuyuki Maintenance ramucirumab monotherapy after intolerable toxicities following docetaxel plus ramucirumab |
| title | Maintenance ramucirumab monotherapy after intolerable toxicities following docetaxel plus ramucirumab |
| title_full | Maintenance ramucirumab monotherapy after intolerable toxicities following docetaxel plus ramucirumab |
| title_fullStr | Maintenance ramucirumab monotherapy after intolerable toxicities following docetaxel plus ramucirumab |
| title_full_unstemmed | Maintenance ramucirumab monotherapy after intolerable toxicities following docetaxel plus ramucirumab |
| title_short | Maintenance ramucirumab monotherapy after intolerable toxicities following docetaxel plus ramucirumab |
| title_sort | maintenance ramucirumab monotherapy after intolerable toxicities following docetaxel plus ramucirumab |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033353/ https://www.ncbi.nlm.nih.gov/pubmed/29983860 http://dx.doi.org/10.18632/oncotarget.25623 |
| work_keys_str_mv | AT hataakito maintenanceramucirumabmonotherapyafterintolerabletoxicitiesfollowingdocetaxelplusramucirumab AT katakaminobuyuki maintenanceramucirumabmonotherapyafterintolerabletoxicitiesfollowingdocetaxelplusramucirumab |